| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3087443 | Pratique Neurologique - FMC | 2011 | 8 Pages |
Abstract
Intravenous immunoglobulins form the cornerstone of treatment of inflammatory neuropathies. Usually requiring a chronic use, this medication requires a good knowledge of the precautions, the dose to use, and evaluation of the clinical benefit obtained by a standardized clinical examination.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
A. Créange,
